Log in to save to my catalogue

S789 Effect of Mirikizumab on Inflammatory Biomarkers in a Phase 2 Study of Patients With Crohn's Di...

S789 Effect of Mirikizumab on Inflammatory Biomarkers in a Phase 2 Study of Patients With Crohn's Di...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2583029574

S789 Effect of Mirikizumab on Inflammatory Biomarkers in a Phase 2 Study of Patients With Crohn's Disease

About this item

Full title

S789 Effect of Mirikizumab on Inflammatory Biomarkers in a Phase 2 Study of Patients With Crohn's Disease

Publisher

Philadelphia, PA: Wolters Kluwer

Journal title

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S367-S367

Language

English

Formats

Publication information

Publisher

Philadelphia, PA: Wolters Kluwer

Subjects

Subjects and topics

More information

Alternative Titles

Full title

S789 Effect of Mirikizumab on Inflammatory Biomarkers in a Phase 2 Study of Patients With Crohn's Disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2583029574

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2583029574

Other Identifiers

ISSN

0002-9270

E-ISSN

1572-0241

DOI

10.14309/01.ajg.0000776688.39678.45

How to access this item